Clinical Trial Update: A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating safety, engraftment, and efficacy of VC-01 in adults with Type 1 Diabetes was terminated; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• VC-01™

Snippet

Sponsor: ViaCyte | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-10-18